Abbott India Ltd - ABBOTT INDIA Share Price

Sector: Pharmaceuticals | ISIN: INE358A01014
₹ 25,920.90 (-0.04%) icon29 May, 2024, 9:49:59 AM
Open
₹ 25,932.50
Prev. Close
₹ 25,932.50
Turnover(lac)
₹ 0.00
Day's High
₹ 25,984.00
Day's Low
₹ 25,717.90
52 Wk High
₹ 29,638.95
52 Wk Low
₹ 21,450.10
Book Value
₹ 2,065.77
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 55,081.91
P/E
45.90
EPS
565.28
Div. Yield
1.58

Abbott India Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/29/2024 9:49:59 AM

    ₹ 25920.9 -11.60 -0.04
  • Open
  • ₹ 25,932.5
  • Prev. Close
  • ₹ 25,932.5
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 25,984
  • Day's Low
  • ₹ 25,717.9
  • 52 Week's High
  • ₹ 29,638.95
  • 52 Week's Low
  • ₹ 21,450.1
  • Book Value
  • ₹ 2,065.77
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 55,081.91
  • P/E
  • 45.9
  • EPS
  • 565.28
  • Divi. Yield
  • 1.58

Abbott India Ltd Corporate Actions

29 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Apr , 2024

12:00 AM

13 Mar , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Jan , 2024

12:00 AM

31 Oct , 2023

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2023

12:00 AM

AGM

Announcement date: 19 May , 2023

View Details

28 Jul , 2023

12:00 AM

19 May , 2023

12:00 AM

Dividend

Dividend amount: 180
Announcement date: 19 May , 2023

View Details

19 May , 2023

12:00 AM

Dividend

Dividend amount: 145
Announcement date: 19 May , 2023

View Details

No Record Found


Abbott India Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Abbott India Ltd SHAREHOLDING SNAPSHOT
29 May , 2024 | 10:08 AM

PROMOTER - TOTAL74.99%

Indian: 0.00%

Foreign: 74.9862%

NON-PROMOTER - TOTAL 25.01%

Institutions: 9.09%

Non-Institutions: 15.93%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Abbott India Ltd FINANCIALS

View Profit & Loss Graph

Abbott India Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Abbott India Ltd

  • Munir Shaikh
  • Chairman (Non-Executive)
  • Kaiyomarz Marfatia
  • Non Executive Director
  • Ambati Venu
  • Non Executive Director
  • Anisha Motwani
  • Independent Director
  • Sudarshan Jain
  • Independent Director
  • Shalini Kamath
  • Independent Director
  • Sabina Ewing
  • Non Executive Director
  • Vivek Vasudev Kamath
  • Managing Director
  • Mahadeo Karnik
  • Director

Summary

Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily within India. It provides products and solutions across various therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc. Its global products include Brufen, Prothiaden, Thyronorm and Leptos.The company has four divisions. The Primary Care division markets products in the areas of pain management and gastroenterology. The Specialty Care-Methabolics and Urology division provides solutions in the areas of thyroid, obesity, diabetes and benign prostatic hyperplasia. The Specialty Care-Neuroscience division has a varied portfolio with specialty products in neurology and psychiatric segments. Hospital Care offers products in the field of anesthesiology and neonatology, such as Forane, Sevorane and Survanta.Abbott India Ltd was originally incorporated on August 22, 1944 as Boots Pure Drug Company (India) Ltd. The company name was changed to The Boots Company (India) Ltd on November 1, 1971, thereafter to Boots Pharmaceuticals Ltd on January 1, 1991. In October 31, 1995 the name was changed to Knoll Pharmaceuticals Ltd, and in July 1, 2002, they got their present name Abbott India Ltd.In the year... Read More


Reports by Abbott India Ltd


Reports by Abbott India Ltd

Company FAQ

No Record Found